LuanP. V.; TienN. D.; HaiN. M.; TienN. D.; DuyenT. T. Real-world analysis of the effect of gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer with EGFR mutations. Journal of 108 - Clinical Medicine and Phamarcy, v. 15, n. Tiếng Anh, 1 tháng 4 2021.